logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

The Salk Institute for Biological Studies


USPTO Granted Patents = 576



Trademarks = 7

Forward Citations = 9,399

Loading Chart...
Loading Chart...

537 inventors (with patents filed for the assignee):

goldMedal Ronald Mark Evans (135 out of 143 patents)

silverMedal Jean E Rivier (101 out of 110 patents)

bronzeMedal Wylie W Vale, Jr (88 out of 100 patents)

4.  Michael Downes (50 out of 50 patents)

5.  Joseph Noel (25 out of 33 patents)

6.  Ruth T Yu (20 out of 20 patents)

7.  Catherine L Rivier (20 out of 20 patents)

8.  Annette R Atkins (19 out of 19 patents)

9.  Fred Harrison Gage (18 out of 40 patents)

10.  Nicholas C Ling (18 out of 29 patents)

11.  Estelita S Ong (17 out of 18 patents)

12.  Silvana Konermann (16 out of 26 patents)

13.  Patrick D Hsu (16 out of 26 patents)

14.  Stephen Fox Heinemann (16 out of 18 patents)

15.  Vincent Giguere (16 out of 17 patents)


Core Competencies:
RNA Targeting Methods
Oncolytic Adenovirus
Genome Editing
Diabetes Treatment
Synthetic Adenoviruses
Terpenoid Production
Progenitor Reprogramming
Cancer Therapies
High Throughput Assays
Environmental Stress Response
Machine Learning Applications
Organoid Generation

576 patents:

1. 12448636 - High-efficiency reconstitution of RNA molecules (2025-10-21),
2. 12437028 - Systems, software and methods for generating training datasets for machine learning applications (2025-10-07),
3. 12404518 - Expression of IPT7 frompromoter increases root mass and carbon sequestration (2025-09-02),
4. 12365878 - Oncolytic adenovirus with enhanced replication properties comprising modifications in E1A, E3, and E4 (2025-07-22),
5. 12305177 - Methods and platforms for sustainable high yield terpenoid production (2025-05-20),
6. 12281324 - Exogenous gene expression in recombinant adenovirus for minimal impact on viral kinetics (2025-04-21),
7. 12253527 - Compositions and methods for treating age-related diabetes and related disorders (2025-03-18),
8. 12213999 - Compositions and methods for treating type 1 and type 2 diabetes and related disorders (2025-02-04),
9. 11981931 - Reprogramming progenitor compositions and methods of use thereof (2024-05-14),
10. 11970720 - RNA targeting methods and compositions (2024-04-30),
11. 11959094 - Methods and compositions for genome editing in non-dividing cells (2024-04-16),
12. 11857809 - Sonogenic stimulation of cells (2024-01-02),
13. 11813337 - Tumor-targeting synthetic adenoviruses and uses thereof (2023-11-14),
14. 11760977 - Compositions and methods for organoid generation and disease modeling (2023-09-19),
15. 11730781 - Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration (2023-08-22),
The Salk Institute for Biological Studies is a renowned non-profit scientific research institute located in La Jolla, California. Founded in 1960 by Jonas Salk, the developer of the polio vaccine, the Salk Institute conducts groundbreaking research in the fields of molecular biology, genetics, neuroscience, and plant biology. Its mission is to understand the fundamental principles of life and use that knowledge to improve human health and address global challenges. With a multidisciplinary approach, the Salk Institute collaborates with scientists from around the world to make significant discoveries and contribute to scientific advancements in various fields.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
576 Patents

#2 in La Jolla, CA

#187 in California

#817 in US

#1,637 in the World

...
La Jolla, CA, United States of America

The Salk Institute for Biological Studies

Forward Citations = 9,399

537 inventors:

goldMedal Ronald Mark Evans (135 out of 143 patents)

silverMedal Jean E Rivier (101 out of 110 patents)

bronzeMedal Wylie W Vale, Jr (88 out of 100 patents)

4.  Michael Downes (50 out of 50 patents)

5.  Joseph Noel (25 out of 33 patents)

Please report any incorrect information to support@idiyas.com
Loading…